Bahrain first to approve Johnson & Johnson COVID-19 vaccine for emergency use

|
PrintFind an error? Report us
Bahrain has approved Johnson & Johnson's one-dose COVID-19 vaccine for emergency use, the first country to do so, the National Health Regulatory Authority (NHRA) said on Thursday.
The small Gulf state already offers citizens and residents free of charge four vaccines: the Pfizer/BioNTech, vaccine, one manufactured by Chinese state-backed pharmaceutical giant Sinopharm, the Oxford-AstraZeneca COVID-19 vaccine and Russia's Sputnik V.
NHRA said the vaccine was for groups at greater risk of developing complications from COVID-19, including the elderly and people with chronic diseases.
Comments
The commenter agrees to the privacy policy of Ynet News and agrees not to submit comments that violate the terms of use, including incitement, libel and expressions that exceed the accepted norms of freedom of speech.
""